Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study-Reference-Cited by-同舟云学术

Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study

Published:2024-05-02 Issue:1 Volume:35 Page:
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Magnolo Nina¹,Cameron Michael C.²,Shahriari Mona³,Geng Bob⁴,Calimlim Brian M.⁵,Teixeira Henrique⁵,Hu Xiaofei⁵,Yang Yang⁵,Liu Yingyi⁵,Zhang Shiyu⁵,Sancho Sanchez Cristina⁵,Altman Katherine⁵,Langley Richard G.⁶

Affiliation:

1. Department of Dermatology and Venereology, University Hospital of Münster, Münster, Germany

2. Department of Dermatology, Mount Sinai, New York, NY, USA

3. Department of Dermatology, Yale University, New Haven, CT, USA

4. Division of Allergy and Immunology, University of California San Diego, and Rady Children’s Hospital, San Diego, CA, USA

5. AbbVie Inc., North Chicago, IL, USA

6. Division of Clinical Dermatology and Cutaneous Science, Dalhousie University, Halifax, Canada

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2024.2344589

Reference33 articles.

1. Atopic dermatitis

2. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017*

3. Patient burden and quality of life in atopic dermatitis in US adults

4. Sleep Disturbances in Adults with Eczema Are Associated with Impaired Overall Health: A US Population-Based Study

5. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis